- Home
- FSEA vs DXR Comparison
FSEA vs DXR Comparison
Compare FSEA & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSEA
- DXR
- Stock Information
- Founded
- FSEA 1890
- DXR 1970
- Country
- FSEA United States
- DXR United States
- Employees
- FSEA N/A
- DXR N/A
- Industry
- FSEA Savings Institutions
- DXR Medical/Dental Instruments
- Sector
- FSEA Finance
- DXR Health Care
- Exchange
- FSEA Nasdaq
- DXR Nasdaq
- Market Cap
- FSEA 43.6M
- DXR 37.6M
- IPO Year
- FSEA N/A
- DXR N/A
- Fundamental
- Price
- FSEA $9.96
- DXR $8.50
- Analyst Decision
- FSEA
- DXR Strong Buy
- Analyst Count
- FSEA 0
- DXR 1
- Target Price
- FSEA N/A
- DXR $24.75
- AVG Volume (30 Days)
- FSEA 5.9K
- DXR 6.8K
- Earning Date
- FSEA 11-08-2024
- DXR 01-01-0001
- Dividend Yield
- FSEA N/A
- DXR N/A
- EPS Growth
- FSEA N/A
- DXR N/A
- EPS
- FSEA N/A
- DXR 0.35
- Revenue
- FSEA $11,390,000.00
- DXR $154,205.00
- Revenue This Year
- FSEA N/A
- DXR N/A
- Revenue Next Year
- FSEA N/A
- DXR N/A
- P/E Ratio
- FSEA N/A
- DXR $24.39
- Revenue Growth
- FSEA N/A
- DXR N/A
- 52 Week Low
- FSEA $8.05
- DXR $7.19
- 52 Week High
- FSEA $10.38
- DXR $10.02
- Technical
- Relative Strength Index (RSI)
- FSEA 55.91
- DXR 54.80
- Support Level
- FSEA $9.53
- DXR $8.01
- Resistance Level
- FSEA $10.09
- DXR $8.51
- Average True Range (ATR)
- FSEA 0.16
- DXR 0.31
- MACD
- FSEA -0.03
- DXR 0.10
- Stochastic Oscillator
- FSEA 54.90
- DXR 99.07
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.